Dermatology
Melasma
2
Pipeline Programs↗
2
Active Trials↗
0
Companies Involved↗
Melasma is an early-stage landscape with 2 programs across 0 companies. 2 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Analysis
Trial Status
10
clinical trials
Completed6 · 60%
Unknown status2 · 20%
Recruiting1 · 10%
Active, not recruiting1 · 10%
Clinical Trials
Trial Activity
10 trials
A Prospective, Randomized, Sham-controlled, Assessor-blinded, Parallel-group Clinical Study to Evaluate the Efficacy and Safety of Microfocused Ultrasound in Patients With Facial Pigmentary Diseases and Rosacea
Active, not recruiting·XXiangya Hospital of Central South University·Preclinical·NCT07667972·200 enrolled
Azelaic Acid 20% vs Hydroquinone 4% in Epidermal Melasma
Completed·GGujranwala medical college District Headquarters Hospital, Gujranwala·N/A·NCT07327983·146 enrolled
Oral Superoxide Dismutase (GLISODin) to Decrease Melasma Severity.
Completed·—·N/A·NCT03878433·40 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)